BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25205099)

  • 1. Histone h1.3 suppresses h19 noncoding RNA expression and cell growth of ovarian cancer cells.
    Medrzycki M; Zhang Y; Zhang W; Cao K; Pan C; Lailler N; McDonald JF; Bouhassira EE; Fan Y
    Cancer Res; 2014 Nov; 74(22):6463-73. PubMed ID: 25205099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-
    Yang D; Sun B; Zhang X; Cheng D; Yu X; Yan L; Li L; An S; Jiang H; Lasorella A; Iavarone A; Zhang S; Zou F; Zhao X
    Cancer Res; 2017 Sep; 77(18):4773-4784. PubMed ID: 28687618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.
    Zhu Z; Song L; He J; Sun Y; Liu X; Zou X
    Int J Clin Exp Pathol; 2015; 8(9):10082-91. PubMed ID: 26617715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H1 linker histone promotes epigenetic silencing by regulating both DNA methylation and histone H3 methylation.
    Yang SM; Kim BJ; Norwood Toro L; Skoultchi AI
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1708-13. PubMed ID: 23302691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus.
    Ito Y; Nativio R; Murrell A
    Nucleic Acids Res; 2013 May; 41(10):5290-302. PubMed ID: 23585276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes.
    Ramani K; Mavila N; Ko KS; Mato JM; Lu SC
    J Biol Chem; 2016 Nov; 291(46):24148-24159. PubMed ID: 27687727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
    Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells.
    Sajadpoor Z; Amini-Farsani Z; Teimori H; Shamsara M; Sangtarash MH; Ghasemi-Dehkordi P; Yadollahi F
    Appl Biochem Biotechnol; 2018 Aug; 185(4):1132-1144. PubMed ID: 29468525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in expression of imprinted genes from the H19/IGF2 loci in a multigenerational model of intrauterine growth restriction (IUGR).
    Gonzalez-Rodriguez P; Cantu J; O'Neil D; Seferovic MD; Goodspeed DM; Suter MA; Aagaard KM
    Am J Obstet Gynecol; 2016 May; 214(5):625.e1-625.e11. PubMed ID: 26880735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.
    Yan L; Zhou J; Gao Y; Ghazal S; Lu L; Bellone S; Yang Y; Liu N; Zhao X; Santin AD; Taylor H; Huang Y
    Oncogene; 2015 Jun; 34(23):3076-84. PubMed ID: 25088204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA H19 Inhibits Cell Viability, Migration, and Invasion Via Downregulation of IRS-1 in Thyroid Cancer Cells.
    Wang P; Liu G; Xu W; Liu H; Bu Q; Sun D
    Technol Cancer Res Treat; 2017 Dec; 16(6):1102-1112. PubMed ID: 29332545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
    Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
    Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.
    Min HY; Lee SC; Woo JK; Jung HJ; Park KH; Jeong HM; Hyun SY; Cho J; Lee W; Park JE; Kwon SJ; Lee HJ; Ni X; Shin YK; Johnson FM; Duvic M; Lee HY
    Clin Cancer Res; 2017 Mar; 23(5):1299-1311. PubMed ID: 27582487
    [No Abstract]   [Full Text] [Related]  

  • 17. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation.
    Jelinic P; Stehle JC; Shaw P
    PLoS Biol; 2006 Oct; 4(11):e355. PubMed ID: 17048991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8.
    Zhao JL; Wang CL; Liu YL; Zhang GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10226-10233. PubMed ID: 31841176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.